Investor Tompkins Mark N.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Tompkins Mark N. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-04-03 13G/A ALMU / Aeluma, Inc. 2,715,833 2,915,833
2025-02-14 13G/A 1,187,500
2025-02-14 13G/A PMNT / Perfect Moment Ltd. 987,825 652,707
2024-11-14 13G PMNT / Perfect Moment Ltd. 987,825
2024-08-14 13G/A GUER / Guerrilla RF, Inc. 427,392 427,392
2024-08-14 13G/A SERV / Serve Robotics Inc. 1,843,750 1,802,161
2024-02-14 13G/A SMTK / SmartKem, Inc. 2,292,162 64,204
2024-02-14 13G/A SERV / Serve Robotics Inc. 1,843,750
2024-02-14 13G/A GUER / Guerrilla RF, Inc. 2,981,225 427,392
2023-02-14 13G/A GUER / Guerrilla RF, Inc. 2,981,225
2023-02-14 13G/A AUGX / Augmedix, Inc. 1,935,120 914,229
2023-02-14 13G/A ALMU / Aeluma, Inc. 2,715,833
2023-02-14 13G/A SMTK / SmartKem, Inc. 2,300,000 2,292,162
2023-02-10 13G 4,750,000
2023-02-10 13G 4,750,000
2023-02-10 13G 4,750,000
2022-02-14 13G 4,750,000
2022-02-14 13G/A SMTK / SmartKem, Inc. 2,300,000
2022-02-14 13G/A 2,632,500
2022-02-14 13G AUGX / Augmedix, Inc. 1,935,120
2021-11-23 13G 2,700,000
2018-02-15 13G AKTS / Akoustis Technologies, Inc. 1,774,294 1,774,294
2018-02-14 13G AKTS / Akoustis Technologies, Inc. 1,774,294
2017-10-20 13D/A XCUR / Exicure, Inc. 1,933,827
2017-06-26 13D XCUR / Exicure, Inc. 1,065,000
2016-02-16 13G ENUM / Enumeral Biomedical Holdings, Inc. 3,500,000
2015-11-24 13G/A PIRS / Pieris Pharmaceuticals, Inc. 2,176,864 1,958,912
2015-07-10 13G PIRS / Pieris Pharmaceuticals, Inc. 2,176,864
2015-02-17 13G 23126J208 / CUR Media, Inc. 2,206,820